UAL
73
3
CRM
65
6
ADT
12
2
FOXA
67
5
SYK
50
4
CVS
27
2
UNP
38
5
GRMN
53
3
ROP
44
6
UA
48
6
CCL
68
6
EW
55
5
KEY
24
2
HES
49
2
SLG
37
6
CA
19
6
GS
65
16
NI
63
5
JPM
59
6
SLB
41
2
UAL
73
3
CRM
65
6
ADT
12
2
FOXA
67
5
SYK
50
4
CVS
27
2
UNP
38
5
GRMN
53
3
ROP
44
6
UA
48
6
CCL
68
6
EW
55
5
KEY
24
2
HES
49
2
SLG
37
6
CA
19
6
GS
65
16
NI
63
5
JPM
59
6
SLB
41
2
Financhill
Back

Tonix Pharmaceuticals Holding 10K Form

Buy
57

TNXP
Tonix Pharmaceuticals Holding

Last Price:
$0.40
Seasonality Move:
8.65%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-13 10Q TNXP/Tonix Pharmaceuticals Holding Quarterly
2023-11-09 10Q TNXP/Tonix Pharmaceuticals Holding Quarterly
2023-08-10 10Q TNXP/Tonix Pharmaceuticals Holding Quarterly
2023-05-08 10Q TNXP/Tonix Pharmaceuticals Holding Quarterly
2022-11-07 10Q TNXP/Tonix Pharmaceuticals Holding Quarterly
2022-08-08 10Q TNXP/Tonix Pharmaceuticals Holding Quarterly

Receive TNXP News And Ratings

See the #1 stock for the next 7 days that we like better than TNXP

TNXP Financial Statistics

Sales & Book Value

Annual Sales: $7.8M
Cash Flow: $-18.8M
Price / Cash Flow: 0
Annual Sales: $0.48
Price / Book: 1.54

Profitability

EPS (TTM): -101.00000
Net Income (TTM): $-135.3M
Gross Margin: $3M
Return on Equity: -150.01%
Return on Assets: -113.77%

Tonix Pharmaceuticals Holding Earnings Forecast

Key Tonix Pharmaceuticals Holding Financial Ratios

  • The Gross Profit Margin over the past 16 years for TNXP is 38.97%.
  • The Selling, General & Administrative Expenses for TNXP have been equal to 447.37% of Gross Profit Margin.
  • The Research & Development expenses have been 1,115.54% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 16 years have been positive in 10 years.

Tonix Pharmaceuticals Holding Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: TNXP
CUSIP: 890260
Website: tonixpharma.com

Debt

Debt-to-Equity Ratio: 0.11
Current Ratio: 3.33
Quick Ratio: 2.52

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TNXP Technical Analysis vs Fundamental Analysis

Buy
57
Tonix Pharmaceuticals Holding (TNXP) is a Buy

Is Tonix Pharmaceuticals Holding a Buy or a Sell?